Protection of MPTP-induced neuroinflammation and neurodegeneration by rotigotine-loaded microspheres

These results suggest that CDS therapy can play a neuroprotective role in an MPTP mouse model. Neuroprotective disease-modifying therapy may have the potential benefits of early treatment by normalizing compensatory mechanisms and may also help to delay dyskinesia in the later stages of PD.